title: [Malignant pancreatic endocrine tumor with isolated raising of serum thyrocalcitonin. Secondary appearance of Zollinger-Ellison syndrome].
authors.forename: R
authors.initials: R
authors.lastname: Benoit
authors.forename: E H
authors.initials: EH
authors.lastname: Metman
authors.forename: Y
authors.initials: Y
authors.lastname: Bacq
authors.forename: J P
authors.initials: JP
authors.lastname: Arnoux
authors.forename: F
authors.initials: F
authors.lastname: Fetissof
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002116:Calcitonin / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D013997:Time Factors; D015043:Zollinger-Ellison Syndrome / Q000209:etiology*
chemical_list: D002116:Calcitonin
vernacular_title: Tumeur endocrine pancréatique maligne avec élévation isolée de thyrocalcitoninémie. Apparition secondaire d'un syndrome de Zollinger-Ellison.